The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Inhaled bronchodilators for cystic fibrosis
Halfhide, C. P., Evans, H. J., & Couriel, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003428.pub2 · Cited by 66
RetractedWebb, A. K. (2006) · Cited by 4,369
Charbonneau, D. H. (2005) · Europe PMC (PubMed Central) · Cited by 2,041
Fuchs, H. J., Borowitz, D. S., Christiansen, D. H., Morris, E. M., Nash, M. L., Ramsey, B. W., Rosenstein, B. J., Smith, A. L., & Wohl, M. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409083311003 · Cited by 1,539
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Early pulmonary inflammation in infants with cystic fibrosis.
Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J., & Riches, D. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697234 · Cited by 1,263
Matsui, H., Grubb, B. R., Tarran, R., Randell, S. H., Gatzy, J. T., Davis, C. W., & Boucher, R. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81724-9 · Cited by 1,169
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U. E., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiß, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13870 · Cited by 1,099
Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiss, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213870 · Cited by 932
Ratjen, F., & Döring, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12567-6 · Cited by 885
A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis
Elkins, M. R., Robinson, M., Rose, B. R., Harbour, C., Moriarty, C. P., Marks, G. B., Belousova, E. G., Xuan, W., & Bye, P. T. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043900 · Cited by 862
H1-Receptor Antagonists: Comparative Tolerability and Safety
Estelle, F., & Simons, R. (1994) · Drug Safety · doi:10.2165/00002018-199410050-00002 · Cited by 751
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
Effect of High-Dose Ibuprofen in Patients with Cystic Fibrosis
Konstan, M. W., Byard, P. J., Hoppel, C. L., & Davis, P. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503303321303 · Cited by 726
Mucus Clearance and Lung Function in Cystic Fibrosis with Hypertonic Saline
Donaldson, S. H., Bennett, W. D., Zeman, K. L., Knowles, M. R., Tarran, R., & Boucher, R. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043891 · Cited by 694
Cystic fibrosis mortality and survival in the UK: 1947–2003
Dodge, J. A., Lewis, P. A., Stanton, M., & Wilsher, J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00099506 · Cited by 627
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
Döring, G., Conway, S. P., Heijerman, H. G. M., Hodson, M. E., Høiby, N., Smyth, A., Touw, D. J., & the Consensus Committee, F. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16d30.x · Cited by 620
Self-citationHeyder, J. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200409-046ta · Cited by 601 · cited 2×
“However, they are studied in aerosol research to gain knowledge on aerosol particle behaviour in vivo [144,197].”
BackgroundRegional Lung Deposition and Bronchodilator Response as a Function of β 2 -Agonist Particle Size
Usmani, O. S., Biddiscombe, M. F., & Barnes, P. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1414oc · Cited by 578
Equi, A., Balfour-Lynn, I., Bush, A., & Rosenthal, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11081-6 · Cited by 543
46th Interscience Conference on Antimicrobial Agents and Chemotherapy
McConnell, J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70621-1 · Cited by 541
Konstan, M. W., Hilliard, K. A., Norvell, T. M., & Berger, M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.2.8049828 · Cited by 520
Wolter, J. (2002) · Thorax · doi:10.1136/thorax.57.3.212 · Cited by 518
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
Valerius, N. H., Koch, C., & Høiby, N. (1991) · The Lancet · doi:10.1016/0140-6736(91)91446-2 · Cited by 475
Frederiksen, B., Koch, C., & Høiby, N. (1997) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199705)23:5<330::aid-ppul4>3.0.co;2-o · Cited by 473
Lower Airway Inflammation in Infants and Young Children with Cystic Fibrosis
ARMSTRONG, D. S., GRIMWOOD, K., CARLIN, J. B., CARZINO, R., GUTIÈRREZ, J. P., HULL, J., OLINSKY, A., PHELAN, E. M., ROBERTSON, C. F., & PHELAN, P. D. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.4.96-11058 · Cited by 467
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Dorkin, H. L., Eisenberg, J. D., Gibson, R. L., Harwood, I. R., Kravitz, R. M., Schidlow, D. V., Wilmott, R. W., Astley, S. J., McBurnie, M. A., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282403 · Cited by 458
Kosorok, M. R., Zeng, L., West, S. E. H., Rock, M. J., Splaingard, M. L., Laxova, A., Green, C. G., Collins, J., & Farrell, P. M. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.2009.abs · Cited by 400
Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis
McCoy, K. S., Quittner, A. L., Oermann, C. M., Gibson, R. L., Retsch-Bogart, G. Z., & Montgomery, A. B. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1804oc · Cited by 356
Aerosol α1 -antitrypsin treatment for cystic fibrosis
McElvaney, N. G., Hubbard, R. C., Birrer, P., Crystal, R. G., Chernick, M. S., Frank, M. M., & Caplan, D. B. (1991) · The Lancet · doi:10.1016/0140-6736(91)91167-s · Cited by 325
Infection Control in Cystic Fibrosis
Saiman, L., & Siegel, J. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.57-71.2004 · Cited by 324
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis
Gibson, R. L., Emerson, J., McNamara, S., Burns, J. L., Rosenfeld, M., Yunker, A., Hamblett, N., Accurso, F., Dovey, M., Hiatt, P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-855oc · Cited by 318
Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P. M., Jones, G., & Bruce, K. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5176-5183.2004 · Cited by 318
Jensen, T., Pedersen, S. S., Garne, S., Heilmann, C., Høiby, N., & Koch, C. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/19.6.831 · Cited by 314
Coming together: the ATS/ERS consensus on clinical pulmonary function testing
Brusasco, V., Crapo, R., & Viegi, G. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034205 · Cited by 313
Saiman, L. (2003) · American Journal of Infection Control · doi:10.1067/mic.2003.78 · Cited by 307
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
Döring, G., & Hoiby, N. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.03.008 · Cited by 304
Quan, J. M., Tiddens, H. A. W. M., Sy, J. P., McKenzie, S. G., Montgomery, M. D., Robinson, P. J., Wohl, M. E. B., & Konstan, M. W. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.118570 · Cited by 301
Pharmacokinetics and Bioavailability of Aerosolized Tobramycin in Cystic Fibrosis
Geller, D. E., Pitlick, W. H., Nardella, P. A., Tracewell, W. G., & Ramsey, B. W. (2002) · Chest · doi:10.1378/chest.122.1.219 · Cited by 300
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis
Hodson, M. E., Gallagher, C. G., & Govan, J. R. W. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00248102 · Cited by 269
Robinson, M., Hemming, A. L., Regnis, J. A., Wong, A. G., Bailey, D. L., Bautovich, G. J., King, M., & Bye, P. T. (1997) · Thorax · doi:10.1136/thx.52.10.900 · Cited by 265
Regelmann, W. E., Elliott, G. R., Warwick, W. J., & Clawson, C. C. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.4_pt_1.914 · Cited by 262
Nebulised hypertonic saline for cystic fibrosis
Wark, P., & McDonald, V. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001506.pub4 · Cited by 248
Quantitative Deposition of Aerosolized Gentamicin in Cystic Fibrosis
Ilowite, J. S., Gorvoy, J. D., & Smaldone, G. C. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.6.1445 · Cited by 247
Ratjen, F., Döring, G., & Nikolaizik, W. H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06124-4 · Cited by 218
Wiesemann, H. G., Steinkamp, G., Ratjen, F., Bauernfeind, A., Przyklenk, B., Döring, G., & von der Hardt, H. (1998) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199802)25:2<88::aid-ppul3>3.0.co;2-j · Cited by 200
α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
Griese, M., Latzin, P., Kappler, M., Weckerle, K., Heinzlmaier, T., Bernhardt, T., & Hartl, D. (2007) · European Respiratory Journal · doi:10.1183/09031936.00047306 · Cited by 198
Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety
Geller, D. E., Konstan, M. W., Smith, J., Noonberg, S. B., & Conrad, C. (2007) · Pediatric Pulmonology · doi:10.1002/ppul.20594 · Cited by 196
Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis
Eng, P. A., Morton, J., Douglass, J. A., Riedler, J., Wilson, J., & Robertson, C. F. (1996) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199602)21:2<77::aid-ppul3>3.0.co;2-m · Cited by 194
Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients
Taccetti, G., Campana, S., Festini, F., Mascherini, M., & Döring, G. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00009605 · Cited by 181
Clinical Use of Ibuprofen Is Associated with Slower FEV 1 Decline in Children with Cystic Fibrosis
Konstan, M. W., Schluchter, M. D., Xue, W., & Davis, P. B. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-181oc · Cited by 178
Park, M. K., Myers, R. A. M., & Marzella, L. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.3.720 · Cited by 172
Nebulizers: Principles and Performance
HESS, D. R. (2000) · Respiratory Care · doi:10.1177/002013240004500605 · Cited by 166
Antimicrobial Activity of Home Disinfectants and Natural Products Against Potential Human Pathogens
Rutala, W. A., Barbee, S. L., Aguiar, N. C., Sobsey, M. D., & Weber, D. J. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501694 · Cited by 159
Long-term Benefits of Inhaled Tobramycin in Adolescent Patients With Cystic Fibrosis
Moss, R. B. (2002) · CHEST Journal · doi:10.1378/chest.121.1.55 · Cited by 156
Suri, R., Metcalfe, C., Lees, B., Grieve, R., Flather, M. D., Normand, C. E. M., Thompson, S. G., Bush, A., & Wallis, C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06412-1 · Cited by 152
Yerxa, B. R., Sabater, J. R., Davis, C. W., Stutts, M. J., Lang-Furr, M., Picher, M., Jones, A. C., Cowlen, M. S., Dougherty, R., Boyer, J. L., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035485 · Cited by 151
McCallion, O. N. M., Taylor, K. M. G., Thomas, M., & Taylor, A. J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016205520044 · Cited by 150
Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P., Jones, G., Kehagia, V., Connett, G. J., & Bruce, K. D. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02282-05 · Cited by 150
Multicenter Randomized Controlled Trial of Withdrawal of Inhaled Corticosteroids in Cystic Fibrosis
Balfour-Lynn, I. M., Lees, B., Hall, P., Phillips, G., Khan, M. A., Flather, M. D., & Elborn, J. S. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200511-1808oc · Cited by 150
Inhaled corticosteroids for cystic fibrosis
Balfour-Lynn, I. M., & Welch, K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001915.pub5 · Cited by 144
Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis
Smith, A. L., Ramsey, B. W., Hedges, D. L., et al. (1989) · Pediatric Pulmonology · doi:10.1002/ppul.1950070413 · Cited by 142
McCoy, K., Hamilton, S., & Johnson, C. A. (1996) · CHEST Journal · doi:10.1378/chest.110.4.889 · Cited by 141
Inhalation of Moli1901 in Patients With Cystic Fibrosis
Grasemann, H., Stehling, F., Brunar, H., Widmann, R. S., Laliberte, T. W., Molina, L., Döring, G., & Ratjen, F. A. (2007) · CHEST Journal · doi:10.1378/chest.06-2085 · Cited by 140
Hogardt, M., Hoboth, C., Schmoldt, S., Henke, C., Bader, L., & Heesemann, J. (2006) · The Journal of Infectious Diseases · doi:10.1086/509821 · Cited by 129
Frederiksen, B., Pressler, T., Hansen, A., et al. (2006) · Acta Paediatrica · doi:10.1080/08035250600752466 · Cited by 127
Risks of Alternate-Day Prednisone in Patients With Cystic Fibrosis
Rosenstein, B. J., & Eigen, H. (1991) · PEDIATRICS · doi:10.1542/peds.87.2.245 · Cited by 125
Murphy, T. D., Anbar, R. D., Lester, L. A., et al. (2004) · Pediatric Pulmonology · doi:10.1002/ppul.20097 · Cited by 118
Olivier, K. N., Bennett, W. D., Hohneker, K. W., Zeman, K. L., Edwards, L. J., Boucher, R. C., & Knowles, M. R. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.1.8680683 · Cited by 117
McElvaney, N. G., Doujaiji, B., Moan, M. J., Burnham, M. R., Wu, M. C., & Crystal, R. G. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.4_pt_1.1056 · Cited by 114
Gibson, R. L., Retsch‐Bogart, G. Z., Oermann, C. M., et al. (2006) · Pediatric Pulmonology · doi:10.1002/ppul.20429 · Cited by 113
Characterization of Nebulized Liposomal Amikacin (Arikace ™ ) as a Function of Droplet Size
Li, Z., Zhang, Y., Wurtz, W., Lee, J. K., Malinin, V., Durwas-Krishnan, S., Meers, P. R., & Perkins, W. R. (2008) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0686 · Cited by 112
van Haren, E. H. J., Lammers, J. J., Festen, J., Heijerman, H. G. M., Groot, C. A. R., & van Herwaarden, C. L. A. (1995) · Respiratory Medicine · doi:10.1016/0954-6111(95)90249-x · Cited by 112
Self-citationImprovement of Alveolar Glutathione and Lung Function but Not Oxidative State in Cystic Fibrosis
Griese, M., Ramakers, J., Krasselt, A. I., Starosta, V., van Koningsbruggen, S., Fischer, R., Ratjen, F. A., Müllinger, B., Huber, R. M., Maier, K., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1104oc · Cited by 112
Inhibition of airway proteases in cystic fibrosis lung disease
Griese, M., Kappler, M., Gaggar, A., & Hartl, D. (2008) · European Respiratory Journal · doi:10.1183/09031936.00146807 · Cited by 112
Eisenberg, J. D., PEPE, M. S., PEPE, M. S., Vasiliev, M., Montgomery, A. B., Smith, A. L., & Ramsey, B. W. (1997) · CHEST Journal · doi:10.1378/chest.111.4.955 · Cited by 111
Retsch‐Bogart, G. Z., Burns, J. L., Otto, K., Liou, T. G., McCoy, K., Oermann, C. M., Gibson, R. L., & AZLI Phase II Study Group (2007) · Pediatric Pulmonology · doi:10.1002/ppul.20736 · Cited by 107
Allen, S. D., Sorensen, K. N., Neial, M. J., Durrant, C., & Proffitt, R. T. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.6.1001 · Cited by 105
Design Principles of Liquid Nebulization Devices Currently in Use
Rau, J. L. (2002) · Respiratory Care · doi:10.1177/002013240204701103 · Cited by 105
Dornase Alfa Reduces Air Trapping in Children With Mild Cystic Fibrosis Lung Disease
Robinson, T. E., Goris, M. L., Zhu, H. J., Chen, X., Bhise, P., Sheikh, F., & Moss, R. B. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2327 · Cited by 101
Safety and Efficacy of Recombinant Alpha1-Antitrypsin Therapy in Cystic Fibrosis
Martin, L., Downey, D. G., Bilton, D., Keogan, M. T., Edgar, J., Elborn, J. S., & on behalf of the Recombinant AAT CF Study Team (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20345 · Cited by 100
Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis
Balfour-Lynn, I. M., Klein, N. J., & Dinwiddie, R. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.2.124 · Cited by 98
Westerman, E. M., Brun, P. P. H. L., Touw, D. J., et al. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2003.12.005 · Cited by 98
Self-citationAdministration of Aerosolized Antibiotics in Cystic Fibrosis Patients
Moss, R. B. (2001) · CHEST Journal · doi:10.1378/chest.120.3_suppl.107s · Cited by 93
Dry powder inhalation of colistin in cystic fibrosis patients: A single dose pilot study
Westerman, E. M., de Boer, A. H., Brun, P. P. H. L., et al. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.10.010 · Cited by 92
Self-citationImamura, Y., Higashiyama, Y., Tomono, K., Izumikawa, K., Yanagihara, K., Ohno, H., Miyazaki, Y., Hirakata, Y., Mizuta, Y., Kadota, J., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1377-1380.2005 · Cited by 92
Pulmonary deposition of aerosols in children with cystic fibrosis
Alderson, P. O., Secker‐Walker, R. H., Strominger, D. B., et al. (1974) · The Journal of Pediatrics · doi:10.1016/s0022-3476(74)80664-5 · Cited by 91
Bronchodilators Increase Airway Instability in Cystic Fibrosis
Zach, M. S., Oberwaldner, B., Forche, G., et al. (1985) · American Review of Respiratory Disease · doi:10.1164/arrd.1985.131.4.537 · Cited by 91
Bronchial Constriction and Inhaled Colistin in Cystic Fibrosis
Alothman, G. A., Ho, B., Alsaadi, M. M., et al. (2005) · CHEST Journal · doi:10.1378/chest.127.2.522 · Cited by 89
Deterding, R. R., Retsch‐Bogart, G. Z., Milgram, L. J. H., Gibson, R. L., Daines, C. L., Zeitlin, P. L., Milla, C. E., Marshall, B. C., LaVange, L. M., Engels, J., et al. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20192 · Cited by 89
Aerosol deposition in infants with cystic fibrosis
Mallol, J., V, Rattray, S., Walker, G. H., Cook, D. J., & Robertson, C. F. (1996) · Pediatric Pulmonology · Cited by 87
Dornase alfa for cystic fibrosis
Jones, A. P., Wallis, C., & Kearney, C. E. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001127 · Cited by 86
Infection and inflammation of the lung in cystic fibrosis
Konstan, M. W., & Berger, M. (1993) · Lung biology in health and disease · Cited by 86
Lowry, C. M., Marty, F. M., Vargas, S. O., Lee, J. T., Fiumara, K., Deykin, A., & Baden, L. R. (2007) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00209.x · Cited by 82
Birke, F. W., Meade, C. J., Anderskewitz, R., Speck, G., & Jennewein, H. M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29557-4 · Cited by 78
Warner, J. O. (1992) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072584 · Cited by 77
Adaptive Aerosol Delivery (AAD®) technology
Denyer, J., Nikander, K., & Smith, N. J. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.165 · Cited by 75
Guideline for Prevention of Nosocomial Pneumonia
SIMMONS, B. P., & Wong, E. S. (1982) · Infection Control · doi:10.1017/s0195941700056423 · Cited by 74
A Phase I Trial of Intranasal Moli1901 for Cystic Fibrosis
Zeitlin, P. L., Boyle, M., Guggino, W. B., & Molina, L. (2004) · CHEST Journal · doi:10.1378/chest.125.1.143 · Cited by 73
Nebulised hypertonic saline for cystic fibrosis
Wark, P. A. B., McDonald, V. M., & Jones, A. P. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001506.pub2 · Cited by 73
Brown, J. S., Zeman, K. L., & Bennett, W. D. (2001) · Journal of Aerosol Medicine · doi:10.1089/08942680152744659 · Cited by 71
Rosenfeld, M., Gibson, R. L., McNamara, S., Emerson, J., McCoy, K. S., SHELL, R. D., Borowitz, D., Konstan, M. W., Retsch‐Bogart, G. Z., Wilmott, R. W., et al. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.117785 · Cited by 70
A Comparison of the Availability of Tobramycin for Inhalation From Vented vs Unvented Nebulizers
Coates, A. L., MacNeish, C. F., Lands, L. C., Meisner, D., Kelemen, S., & Vadas, E. B. (1998) · CHEST Journal · doi:10.1378/chest.113.4.951 · Cited by 69
Conley, J., Yang, H., Wilson, T., Blasetti, K. L., Dininno, V., Schnell, G., & Wong, J. P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1288 · Cited by 68
Alothman, G. A., Alsaadi, M. M., Ho, B., et al. (2002) · CHEST Journal · doi:10.1378/chest.122.3.930 · Cited by 68
Ballmann, M., & von der Hardt, H. (2002) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(01)00009-1 · Cited by 67
Home nebulizer use among patients with cystic fibrosis
Rosenfeld, M., Emerson, J., Astley, S. J., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70497-4 · Cited by 66
Comparison of drug delivery from conventional versus "Venturi" nebulizers
Devadason, S. G., Everard, M. L., Linto, J., & Souëf, P. N. L. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10112479 · Cited by 65
Use of Secretory Leukoprotease Inhibitor to Augment Lung Antineutrophil Elastase Activity
Vogelmeier, C. F., Gillissen, A., & Buhl, R. (1996) · CHEST Journal · doi:10.1378/chest.110.6_supplement.261s · Cited by 59
Inhaled corticosteroids for cystic fibrosis
Balfour-Lynn, I. M., Walters, S., & Dezateux, C. A. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001915 · Cited by 56
Coates, A. L., Allen, P. D., MacNeish, C. F., Ho, S. L., & Lands, L. C. (2001) · CHEST Journal · doi:10.1378/chest.119.4.1123 · Cited by 52
Regional lung deposition of nebulized liposome-encapsulated ciprofloxacin
Finlay, W. H., & Wong, J. P. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00055-6 · Cited by 51
A Controlled Trial of Long-term Bronchodilator Therapy in Cystic Fibrosis
Eggleston, P. A., Rosenstein, B. J., Stackhouse, C. M., Mellits, E. D., & Baumgardner, R. A. (1991) · CHEST Journal · doi:10.1378/chest.99.5.1088 · Cited by 51
Wojtczak, H. A., Kerby, G. S., Wagener, J. S., Copenhaver, S. C., Gotlin, R. W., Riches, D. W. H., & Accurso, F. J. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.1122 · Cited by 49
Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis
Nikolaizik, W. H., Trociewicz, K., & Ratjen, F. A. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00264002 · Cited by 48
Moskowitz, S. M., Gibson, R. L., & Effmann, E. L. (2005) · Pediatric Radiology · doi:10.1007/s00247-005-1445-3 · Cited by 45
Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis
Dequin, P. F., Faurisson, F., Lemarié, É., Delatour, F., Marchand, S., Valat, C., Boissinot, E., de Gialluly, C., & Diot, P. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.99086801 · Cited by 42
Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?
Boeck, K. D., Baets, F. D., Malfroot, A., Desager, K., Mouchet, F., & Proesmans, M. (2006) · European Journal of Pediatrics · doi:10.1007/s00431-006-0198-9 · Cited by 41
Eber, E., Oberwaldner, B., & Zach, M. S. (1988) · Pediatric Pulmonology · doi:10.1002/ppul.1950040404 · Cited by 38
Liposomal Aerosols in the Management of Pulmonary Infections
Gilbert, B. E. (1996) · Journal of Aerosol Medicine · doi:10.1089/jam.1996.9.111 · Cited by 38
Residual Gravimetric Method to Measure Nebulizer Output
None, L. V., Grimbert, D., Bordenave, J., Benoît, G., Furet, Y., Fauroux, B., Boissinot, E., Monte, M. D., Lemarié, É., & Diot, P. (2004) · Journal of Aerosol Medicine · doi:10.1089/089426804322994479 · Cited by 35
Marshall, B. G., Wangoo, A., Harrison, L. I., Young, D. B., & Shaw, R. J. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15d22.x · Cited by 32
Jakobsson, B., Hjelte, L., & Nyström, B. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.1999.0658 · Cited by 30
Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis
Dodd, J. D., Barry, S. C., Daly, L., & Gallagher, C. G. (2005) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.11.004 · Cited by 29
An evaluation of two aerosol delivery systems for rhDNase
Shah, P. L., Scott, S., Geddes, D., et al. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10061261 · Cited by 29
Coates, A. L., Green, M., Leung, K., Louca, E., Tservistas, M., Chan, J., Ribeiro, N., & Charron, M. (2007) · Journal of Aerosol Medicine · doi:10.1089/jam.2007.0620 · Cited by 28
Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis
Adeboyeku, D., Scott, S. F., & Hodson, M. E. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.05.009 · Cited by 27
Pathogenesis of cystic fibrosis airways disease.
Boucher, R. (2001) · PubMed Central · Cited by 25
Inhaled Amphotericin B for Prophylaxis Against Invasive Aspergillus Infections
Mohammad, R. A., & Klein, K. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g477 · Cited by 25
Köhler, E., Sollich, V., Schuster-Wonka, R., & Jorch, G. (2005) · Journal of Aerosol Medicine · doi:10.1089/jam.2005.18.386 · Cited by 23
Can Tobramycin Inhalation Be Improved With a Jet Nebulizer?
Brun, P. P. H. L., Vinks, A. A. T. M. M., Touw, D. J., et al. (1999) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199912000-00007 · Cited by 22
Self-citationLung Deposition in Cystic Fibrosis Patients Using an Ultrasonic or a Jet Nebulizer
Köhler, E., Sollich, V., Schuster-Wonka, R., & Hühnerbein, J. (2003) · Journal of Aerosol Medicine · doi:10.1089/089426803764928347 · Cited by 21
Catheter cleaning for re-use in intermittent catheterization: new light on an old problem.
Lavallée, D. J., Lapierre, N. M., Henwood, P. K., Pivik, J. R., Best, M., Springthorpe, V. S., & Sattar, S. (1995) · PubMed · Cited by 19
Effect of Albuterol on Maximal Exercise Capacity in Cystic Fibrosis
Serisier, D. J., Coates, A., & Bowler, S. (2007) · CHEST Journal · doi:10.1378/chest.06-1697 · Cited by 18
Comparison Study of Home Catheter Cleaning Methods
Kurtz, M. J., Zandt, K. V., & Burns, J. L. (1995) · Rehabilitation Nursing · doi:10.1002/j.2048-7940.1995.tb01629.x · Cited by 18
Safety of aerosolized amphotericin B
Knechtel, S. A., & Klepser, M. E. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.5.523 · Cited by 17
Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
Rod, L., & Hoyt, K. S. (2007) · Advanced Emergency Nursing Journal · doi:10.1097/01.tme.0000270333.96508.7d · Cited by 4
Cited by
ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014
Høiby, N., Bjarnsholt, T., Moser, C., Bassi, G. L., Coenye, T., Donelli, G., Hall-Stoodley, L., Holá, V., Imbert, C., Kirketerp-Møller, K., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.10.024 · Cited by 726
European cystic fibrosis society standards of care: best practice guidelines
Smyth, A. R., Bell, S. C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S. J., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.010 · Cited by 582
Physicochemical properties of mucus and their impact on transmucosal drug delivery
Leal, J., Smyth, H. D. C., & Ghosh, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.018 · Cited by 560
Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery
Willis, L., Hayes, D., & Mansour, H. M. (2012) · Lung · doi:10.1007/s00408-011-9360-x · Cited by 148
Hoo, Z. H., Curley, R., Campbell, M. J., Walters, S. J., Hind, D., & Wildman, M. J. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s105530 · Cited by 27
Metadata
- Authors
- Heijerman, H., Westerman, E., Conway, S., & Touw, D.
- Venue
- Journal of Cystic Fibrosis
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 8
- Issue
- 5
- Pages
- 295-315
- ISSN
- 1569-1993 (ISSN-L)
- OpenAlex
- W2124212409
- Cited by
- 264
- References
- 139
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.